Literature DB >> 11286382

Ornithine carbamoyltransferase deficiency: improved sensitivity of testing for protein tolerance in the diagnosis of heterozygotes.

M Potter1, J W Hammond, K G Sim, A K Green, B Wilcken.   

Abstract

The most direct test of functional capacity of the liver in nitrogen disposal is to stress the urea cycle with a high protein load. This has been used in the diagnosis of heterozygosity for ornithine carbamoyltransferase deficiency for many years by measuring the subsequent excretion of orotic acid in urine. Reports have shown some ambiguity in both this and the more recent allopurinol test. We investigated the effects of different foods as the protein load and of different analytical methods. A standardized protocol was developed, giving 35 g protein per m2 surface area as steamed fat-free chicken breast to be eaten within 30 min. Urine was collected at zero time and over 0-2, 2-4 and 4-6 h. Compliance was checked by assessing excretion of amino acids. Diagnostic sensitivity was improved by reference to the change in excretion, i.e. the ratio of excretions 2-4 h/0-2 h. Extension of the test to 6 h gave no diagnostic advantage over a 4 h test. Comparison of the analysis of total orotic acids by the photometric method of Harris and Oberholtzer, the reference method for this study, with that by the method of Goldstein and colleagues showed that the latter gave erratic results with some false positives. However, comparison of the method of Harris and Oberholtzer with specific orotic acid analysis by a modification of the stable-isotope internal standard method of Rimoldi and colleagues yielded the same diagnoses. The improved protein load test gave a clearly positive result in all 16 obligate heterozygotes and 2 possible heterozygotes tested from 14 kindred, and a clearly negative result in all 18 control subjects and all 6 of the possible heterozygotes who were later shown by DNA studies not to carry the family mutation. The test appears at least as sensitive and specific as the allopurinol test, and is more convenient because of the short period of sample collection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286382     DOI: 10.1023/a:1005682017337

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

1.  Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.

Authors:  E R Hauser; J E Finkelstein; D Valle; S W Brusilow
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

2.  Benign persistent orotic aciduria and the possibility of misdiagnosis of ornithine carbamoyltransferase deficiency.

Authors:  K H Carpenter; M Potter; J W Hammond; B Wilcken
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

3.  Metabolic and genetic studies of a family with ornithine transcarbamylase deficiency.

Authors:  A S Goldstein; N J Hoogenraad; J D Johnson; K Fukanaga; E Swierczewski; H M Cann; P Sunshine
Journal:  Pediatr Res       Date:  1974-01       Impact factor: 3.756

4.  Orotic acid in food milk powders.

Authors:  P O Okonkwo; J E Kinsella
Journal:  Am J Clin Nutr       Date:  1969-05       Impact factor: 7.045

5.  A new stable-isotope dilution method for measurement of orotic acid utilizing solvent-extracted urine.

Authors:  M Rimoldi; P Bergomi; A Romeo; S DiDonato
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Conditions affecting the colorimetry of orotic acid and orotidine in urine.

Authors:  M L Harris; V G Oberholzer
Journal:  Clin Chem       Date:  1980-03       Impact factor: 8.327

7.  Carrier detection in ornithine transcarbamylase deficiency.

Authors:  J T Hokanson; W E O'Brien; J Idemoto; I A Schafer
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

8.  Optimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency.

Authors:  J A Arranz; E Riudor; M Rodés; M Roig; C Climent; V Rubio; M Sentís; A Burlina
Journal:  Clin Chem       Date:  1999-07       Impact factor: 8.327

9.  The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease.

Authors:  J R Bonham; P Guthrie; M Downing; J C Allen; M S Tanner; M Sharrard; C Rittey; J M Land; A Fensom; D O'Neill; J A Duley; L D Fairbanks
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

10.  Allopurinol challenge test in children.

Authors:  A B Burlina; V Ferrari; C Dionisi-Vici; A Bordugo; F Zacchello; M Tuchman
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

View more
  4 in total

1.  How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency?

Authors:  S Grünewald; L Fairbanks; S Genet; T Cranston; J Hüsing; J V Leonard; M P Champion
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 2.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

3.  Phenotypic flexibility as a measure of health: the optimal nutritional stress response test.

Authors:  Johanna H M Stroeve; Herman van Wietmarschen; Bas H A Kremer; Ben van Ommen; Suzan Wopereis
Journal:  Genes Nutr       Date:  2015-04-21       Impact factor: 5.523

4.  Hyperinsulinism-hyperammonemia Syndrome in an Infant with Seizures.

Authors:  A Strajnar; M Z Tansek; K T Podkrajsek; T Battelino; U Groselj
Journal:  Balkan J Med Genet       Date:  2018-10-29       Impact factor: 0.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.